BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 35922752)

  • 1. Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysis.
    Maleknia S; Tavassolifar MJ; Mottaghitalab F; Zali MR; Meyfour A
    Mol Med; 2022 Aug; 28(1):86. PubMed ID: 35922752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood.
    Ng DL; Granados AC; Santos YA; Servellita V; Goldgof GM; Meydan C; Sotomayor-Gonzalez A; Levine AG; Balcerek J; Han LM; Akagi N; Truong K; Neumann NM; Nguyen DN; Bapat SP; Cheng J; Martin CS; Federman S; Foox J; Gopez A; Li T; Chan R; Chu CS; Wabl CA; Gliwa AS; Reyes K; Pan CY; Guevara H; Wadford D; Miller S; Mason CE; Chiu CY
    Sci Adv; 2021 Feb; 7(6):. PubMed ID: 33536218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.
    Gupta RK; Rosenheim J; Bell LC; Chandran A; Guerra-Assuncao JA; Pollara G; Whelan M; Artico J; Joy G; Kurdi H; Altmann DM; Boyton RJ; Maini MK; McKnight A; Lambourne J; Cutino-Moguel T; Manisty C; Treibel TA; Moon JC; Chain BM; Noursadeghi M;
    Lancet Microbe; 2021 Oct; 2(10):e508-e517. PubMed ID: 34250515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations.
    Fan G; Qin X; Streblow DN; Hoyos CM; Hansel DE
    Microbiol Spectr; 2021 Sep; 9(1):e0006221. PubMed ID: 34431689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
    Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
    J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning-driven blood transcriptome-based discovery of SARS-CoV-2 specific severity biomarkers.
    Krishnamoorthy P; Raj AS; Kumar H
    J Med Virol; 2023 Feb; 95(2):e28488. PubMed ID: 36625381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 2-Gene Host Signature for Improved Accuracy of COVID-19 Diagnosis Agnostic to Viral Variants.
    Albright J; Mick E; Sanchez-Guerrero E; Kamm J; Mitchell A; Detweiler AM; Neff N; Tsitsiklis A; Hayakawa Serpa P; Ratnasiri K; Havlir D; Kistler A; DeRisi JL; Pisco AO; Langelier CR
    mSystems; 2023 Feb; 8(1):e0067122. PubMed ID: 36507688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.
    Zhang C; Feng YG; Tam C; Wang N; Feng Y
    Front Immunol; 2021; 12():733171. PubMed ID: 34880855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19.
    Liu Y; Wu Y; Liu B; Zhang Y; San D; Chen Y; Zhou Y; Yu L; Zeng H; Zhou Y; Zhou F; Yang H; Yin L; Huang Y
    Front Immunol; 2021; 12():677025. PubMed ID: 34504487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.
    Hoque MN; Sarkar MMH; Khan MA; Hossain MA; Hasan MI; Rahman MH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Nafisa T; Molla MMA; Soliman ME; Araf Y; Khan MS; Zheng C; Islam T
    Front Immunol; 2022; 13():918692. PubMed ID: 36059456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
    Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
    Front Immunol; 2021; 12():789317. PubMed ID: 34975885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab.
    Sims JT; Poorbaugh J; Chang CY; Holzer TR; Zhang L; Engle SM; Beasley S; Doman TN; Naughton L; Higgs RE; Kallewaard N; Benschop RJ
    J Transl Med; 2022 Mar; 20(1):134. PubMed ID: 35303909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.
    Petruccioli E; Najafi Fard S; Navarra A; Petrone L; Vanini V; Cuzzi G; Gualano G; Pierelli L; Bertoletti A; Nicastri E; Palmieri F; Ippolito G; Goletti D
    J Transl Med; 2021 Jun; 19(1):272. PubMed ID: 34174875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples.
    Biji A; Khatun O; Swaraj S; Narayan R; Rajmani RS; Sardar R; Satish D; Mehta S; Bindhu H; Jeevan M; Saini DK; Singh A; Gupta D; Tripathi S
    EBioMedicine; 2021 Aug; 70():103525. PubMed ID: 34392148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic comparison of published host gene expression signatures for bacterial/viral discrimination.
    Bodkin N; Ross M; McClain MT; Ko ER; Woods CW; Ginsburg GS; Henao R; Tsalik EL
    Genome Med; 2022 Feb; 14(1):18. PubMed ID: 35184750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive analysis of gene expression profiling data in COVID-19 patients for discovery of specific and differential blood biomarker signatures.
    Momeni M; Rashidifar M; Balam FH; Roointan A; Gholaminejad A
    Sci Rep; 2023 Apr; 13(1):5599. PubMed ID: 37019895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.
    Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S
    Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in Peru.
    Calderón RI; Jhaveri TA; Tovar MA; Palomino JS; Barreda NN; Sanabria OM; Peinado J; Ramirez C; Llanos Zavalaga LF; Valderrama G; Franke MF; Mitnick CD; Lecca L; Velásquez GE
    Microbiol Spectr; 2022 Aug; 10(4):e0086122. PubMed ID: 35867471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Expression Meta-Analysis Reveals Interferon-Induced Genes Associated With SARS Infection in Lungs.
    Park A; Harris LK
    Front Immunol; 2021; 12():694355. PubMed ID: 34367154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.
    Huang Z; Ning B; Yang HS; Youngquist BM; Niu A; Lyon CJ; Beddingfield BJ; Fears AC; Monk CH; Murrell AE; Bilton SJ; Linhuber JP; Norton EB; Dietrich ML; Yee J; Lai W; Scott JW; Yin XM; Rappaport J; Robinson JE; Saba NS; Roy CJ; Zwezdaryk KJ; Zhao Z; Hu TY
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33561010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.